Find a Startup

Impacting society, creating change

Technologies developed at Ohio State are changing the world. Learn more about the startups that are currently a part of the Ohio State portfolio or download our printable catalog (as of June 30, 2019).

Search for a Startup below

Categories Filter
  • All
  • Advanced Materials
  • Agriculture, Food Science & Nutrition
  • Animal Health
  • Electronics, Communications & Networking
  • Energy & Environment
  • Health & Wellness
  • Healthcare IT
  • Medical Devices, Diagnostics & Imaging
  • Research Tools & Reagents
  • Robotics, Sensors & Advanced Manufacturing
  • Software & Information Technology
  • Therapeutics, Drug Delivery & Biotechnology
Showing 1-5 of 90 results
Capture Medical, Inc.
Medical Devices, Diagnostics & Imaging
College of Medicine
License Fiscal Year: 2020
Inventor(s): Nudaparambil Jacob
CEO: Scott Barnes
Otologics
Medical Devices, Diagnostics & Imaging
College of Medicine
License Fiscal Year: 2020
Inventor(s): Metin Gurcan
CEO: Dan Wegner
Matsaki
Robotics, Sensors & Advanced Manufacturing
College of Engineering
License Fiscal Year: 2020
Inventor(s): Sanjay Krishna
CEO: Earl Fuller
Engage Health
Medical Devices, Diagnostics & Imaging

Engage Health’s primary care skin cancer diagnostic tool is based on infrared optics technology developed at Ohio State and the James Cancer Hospital. The diagnostic tool is non-invasive, quick operating, and easy to use. As a result, this diagnostic tool accomplishes the following: increases referral effectiveness by doctors, generates revenue for primary care facilities, and reduces patient anxiety by eliminating both the diagnosis waiting times and lengthy referral process. 

College of Arts & Sciences
License Fiscal Year: 2020
Inventor(s): Jim Coe
CEO: Doug Cohen
Eikonoklastes
Therapeutics, Drug Delivery & Biotechnology

Eikonoklastes Therapeutics is a preclinical stage biopharmaceutical company developing a novel immunotherapy based on Ohio State research to treat several diseases with significant unmet clinical need. Triple-Negative Breast Cancer (TNBC), is a devastating subtype in urgent need of a novel therapy, is the lead indication. Breast cancer is the most common newly diagnosed cancer and the second leading cause of death among women in the United States. Breast cancer deaths are largely the result of recurrent and metastatic disease that typically does not respond well to current treatments.

College of Medicine
License Fiscal Year: 2020
Inventor(s): Zhiwei Hu
CEO: Bruce Halpryn